Effects of Oral Supplementation of Arginine, Zinc and Vitamin C on Collagen Synthesis in Inguinal Hernia Patients
The Effect of a Pre- and Postoperative Oral Supplement of Arginine, Zinc and Vitamin C on Collagen Synthesis in Surgical Inguinal Hernia Patients: A Randomized Controlled Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
Collagen synthesis is depressed systemically in the immediate postoperative period. Arginine, zinc and vitamin C impact collagen synthesis. The aim of this study is to investigate the effect of a pre and postoperative oral supplement consisting of arginine, zinc and vitamin C on collagen synthesis in patients undergoing inguinal hernia repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2017
CompletedJune 6, 2018
July 1, 2017
12 months
March 30, 2017
June 4, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in CICP levels in serum. CICP is the biomarker of type I collagen synthesis (carboxy-terminal propeptide of type I procollagen)
CICP is measured by enzyme-linked immunosorbent assay
Day 2
Secondary Outcomes (8)
Changes in CICP levels in wound fluid collected from surgical drain. CICP is the biomarker of type I collagen synthesis (carboxy-terminal propeptide of type I procollagen).
Day 1 and day 2
Changes in CICP levels in wound fluid collected from suction blisters. CICP is the biomarker of type I collagen synthesis (carboxy-terminal propeptide of type I procollagen).
Day 0
Changes in Zinc levels in serum
Day -14, day 0, day 1 and day 2
Changes in Zinc levels in wound fluid collected from surgical drain
Day 1 and day 2
Changes in Zinc levels in wound fluid collected from suction blisters
Day 0
- +3 more secondary outcomes
Study Arms (2)
Control
PLACEBO COMPARATORTotal daily protein intake: 1.5 g protein/kg body weight
Intervention
ACTIVE COMPARATOR55 mg zinc/day, 1251 mg vitamin C/day, and 15 g arginine/day. Total daily protein intake: 1.5 g protein/kg body weight
Interventions
The patients in the intervention group are given 55 mg zinc, 1251 mg vitamin C, and 15 g arginine once daily 14 days pre-operatively and post-operatively together with a high quality protein supplement.
High quality protein supplement 14 days pre-operatively and post-operatively.
Eligibility Criteria
You may qualify if:
- Age above 18 years
- Patients undergoing hernia repair using the Lichtenstein technique
- Written informed consent
You may not qualify if:
- Former surgery in the same area within 5 years
- Dementia
- Dysregulated diabetes
- Systemic corticosteroid treatment
- Liver disease
- Kidney disease
- Cancer within 5 years
- Need of interpreter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bispebjerg Hospital
Copenhagen, Copenhagen NV, 2400, Denmark
Related Publications (1)
Kjaer M, Frederiksen AKS, Nissen NI, Willumsen N, van Hall G, Jorgensen LN, Andersen JR, Agren MS. Multinutrient Supplementation Increases Collagen Synthesis during Early Wound Repair in a Randomized Controlled Trial in Patients with Inguinal Hernia. J Nutr. 2020 Apr 1;150(4):792-799. doi: 10.1093/jn/nxz324.
PMID: 31897483DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars N Joergensen
K. Forskning, BIspebjerg Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, MD, DrMedSci
Study Record Dates
First Submitted
March 30, 2017
First Posted
July 18, 2017
Study Start
February 20, 2016
Primary Completion
February 1, 2017
Study Completion
December 10, 2017
Last Updated
June 6, 2018
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share